- Home
- DERM vs SENS Comparison
DERM vs SENS Comparison
Compare DERM & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DERM | SENS |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.0M | 225.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DERM | SENS |
|---|---|---|
| Price | $8.73 | $7.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $12.67 | ★ $25.58 |
| AVG Volume (30 Days) | 143.6K | ★ 464.5K |
| Earning Date | 11-12-2025 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $59,399,000.00 | $29,298,000.00 |
| Revenue This Year | $17.48 | $59.55 |
| Revenue Next Year | $55.83 | $70.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.82 | ★ 31.94 |
| 52 Week Low | $3.63 | $5.25 |
| 52 Week High | $9.56 | $28.00 |
Technical Indicators
Market Signals| Indicator | DERM | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 58.44 |
| Support Level | $7.66 | $6.98 |
| Resistance Level | $9.00 | $7.74 |
| Average True Range (ATR) | 0.55 | 0.49 |
| MACD | 0.17 | 0.05 |
| Stochastic Oscillator | 69.63 | 63.56 |
Price Performance
Historical ComparisonAbout DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.